EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Longitudinal Changes in IgG N-glycome Are Associated with Disease Severity and Mortality in COVID-19 Patients

Martina Vinicki iD, Frano Vučković, Kristian Bodulić iD, Alemka Markotić, Zoran Barušić, Renata Laškaj, Ivan Christian Kurolt iD, Sanja Zember, Rok Čivljak iD, Ivan Puljiz, Gordan Lauc, Tea Pribić

Viruses · 2026

DOI: 10.3390/v18090960 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2026. Verfasst von Martina Vinicki und 11 weiteren Autor:innen. Beteiligte Einrichtung: Genos Glycoscience Research Laboratory, 10 000 Zagreb, Croatia. Hauptthemen laut MEDLINE: Immunoglobulin G, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Center of Competence in Molecular Diagnostics (CEKOM) project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe COVID-19 is characterized by immune dysregulation, yet reliable biomarkers associated with adverse outcomes remain limited. Immunoglobulin G (IgG) N-glycosylation modulates antibody effector function and reflects the immune system’s inflammatory state. In this study, we investigated whether specific IgG glycosylation profiles are associated with COVID-19 severity, mortality, and clinical course in patients without known prior SARS-CoV-2 infection. Of the 806 admitted COVID-19 patients included in the study, 377 hospitalized patients were longitudinally monitored, and 2001 serum samples were analyzed. Significant alterations in IgG N-glycome composition were observed in patients with severe disease and those who died. The most prominent changes included increased agalactosylation and decreased mono- and digalactosylation, features associated with a more pro-inflammatory IgG glycosylation profile. Nosocomial infections were associated with a more pro-inflammatory IgG glycosylation profile. No statistically significant differences in IgG N-glycome composition were observed between vaccinated and unvaccinated patients, although the small number of vaccinated patients limited this analysis. The observed glycomic profiles likely reflect immune responses characteristic of the early phase of the COVID-19 pandemic. Whether similar glycosylation changes occur in other infectious or inflammatory diseases remains to be established. IgG glycosylation analysis holds promise for personalized risk stratification and early therapeutic intervention in COVID-19 and other severe infectious diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin GCOVID-19HumansGlycosylationFemaleSeverity of Illness IndexLongitudinal StudiesMaleMiddle AgedSARS-CoV-2AgedAntibodies, ViralGlycomicsBiomarkersAdultPandemics

Stichwörter der Autor:innen

COVID-19IgG glycosylationbiomarkersdisease severitymortality

Substanzen

Immunoglobulin GAntibodies, ViralBiomarkers

Autor:innen und Institutionen

  • Genos Glycoscience Research Laboratory, 10 000 Zagreb, Croatia.
  • University Hospital for Infectious Diseases, 10 000 Zagreb, Croatia.
  • Faculty of Medicine, Catholic University of Croatia, 10 000 Zagreb, Croatia.
  • Faculty of Medicine, University of Rijeka, 51 000 Rijeka, Croatia.
  • School of Medicine, University of Zagreb, 10 000 Zagreb, Croatia.
  • Department of Biochemistry and Molecular Biology, Faculty of Pharmacy and Biochemistry, University of Zagreb, 10 000 Zagreb, Croatia.

ORCID-Profile: Martina Vinicki, Kristian Bodulić, Ivan Christian Kurolt, Rok Čivljak

Förderung

  • The Center of Competence in Molecular Diagnostics (CEKOM) project

Zitieren

APA

Vinicki, M., Vučković, F., Bodulić, K., Markotić, A., Barušić, Z., Laškaj, R., Kurolt, I. C., Zember, S., Čivljak, R., Puljiz, I., Lauc, G., & Pribić, T. (2026). Longitudinal Changes in IgG N-glycome Are Associated with Disease Severity and Mortality in COVID-19 Patients. Viruses. https://doi.org/10.3390/v18090960

Vancouver

Vinicki M, Vučković F, Bodulić K, Markotić A, Barušić Z, Laškaj R, et al. Longitudinal Changes in IgG N-glycome Are Associated with Disease Severity and Mortality in COVID-19 Patients. Viruses. 2026. doi:10.3390/v18090960

BibTeX
@article{Vinicki2026,
  author = {Vinicki, Martina and Vučković, Frano and Bodulić, Kristian and Markotić, Alemka and Barušić, Zoran and Laškaj, Renata and Kurolt, Ivan Christian and Zember, Sanja and Čivljak, Rok and Puljiz, Ivan and Lauc, Gordan and Pribić, Tea},
  title = {Longitudinal Changes in IgG N-glycome Are Associated with Disease Severity and Mortality in COVID-19 Patients},
  journal = {Viruses},
  year = {2026},
  doi = {10.3390/v18090960}
}
Kostenlos starten →